Hyaluronic acid derivative; viscosupplement

This page covers all Hyaluronic acid derivative; viscosupplement drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Hyaluronic acid receptor (CD44); joint synovial fluid, Synovial fluid; joint cartilage surfaces, Hyaluronic acid receptors (CD44, RHAMM).

Targets

Hyaluronic acid receptor (CD44); joint synovial fluid · Synovial fluid; joint cartilage surfaces · Hyaluronic acid receptors (CD44, RHAMM)

Marketed (2)

• viscosupplementation 1+1+1 · University of Sao Paulo General Hospital · Orthopedics; Rheumatology
  Viscosupplementation 1+1+1 is a hyaluronic acid-based intra-articular injection that restores joint lubrication and provides cushioning to damaged cartilage.
• Synvisc-One · Nature Cell Co. Ltd. · Orthopedics; Rheumatology
  Synvisc-One is a hyaluronic acid-based viscosupplement that lubricates and cushions the knee joint to reduce pain and improve mobility in osteoarthritis.

Phase 3 pipeline (3)

• Synovian inj · Shin Poong Pharmaceutical Co. Ltd. · Rheumatology; Orthopedics
  Synovian is a hyaluronic acid-based intra-articular injection that lubricates and cushions joint cartilage to reduce pain and improve mobility in osteoarthritis.
• High hyal Plus inj. · Huons Co., Ltd. · Orthopedics / Dermatology
  High hyal Plus is a hyaluronic acid-based injectable that provides viscoelastic supplementation and tissue hydration for joint or dermatological applications.
• HA 0.3% · Huons Co., Ltd. · Ophthalmology or Dermatology
  HA 0.3% is a hyaluronic acid-based topical or injectable formulation that provides hydration, lubrication, and tissue support through its viscoelastic properties.

Patent intelligence

• hyaluronic acid derivative patent landscape — aggregated cliff calendar, attackable patents, originator estates